These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 16264875)
21. Progress in immunotherapy rituximab. El-Habbash MM; Alwindi AM Saudi Med J; 2007 Nov; 28(11):1635-44. PubMed ID: 17965780 [TBL] [Abstract][Full Text] [Related]
22. Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma. Tam CS; Wolf M; Prince HM; Januszewicz EH; Westerman D; Lin KI; Carney D; Seymour JF Cancer; 2006 Jun; 106(11):2412-20. PubMed ID: 16649223 [TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus-associated meningoradiculoneuritis after treatment of mantle cell lymphoma with a combination of chemotherapy and rituximab. Vallet S; Tempescul A; Tran A; Legrand-Quillien MC; Narbonne V; Berthou C Ann Hematol; 2005 Aug; 84(8):545-7. PubMed ID: 15789227 [No Abstract] [Full Text] [Related]
24. Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma. Robak T; Smolewski P; Cebula B; Szmigielska-Kaplon A; Chojnowski K; Blonski JZ Cancer; 2006 Oct; 107(7):1542-50. PubMed ID: 16948126 [TBL] [Abstract][Full Text] [Related]
25. Combination biologic therapy without chemotherapy as initial treatment for mantle cell lymphoma: multi- center phase II study of lenalidomide plus rituximab. Clin Adv Hematol Oncol; 2014 Feb; 12(2 Suppl 6):17-8. PubMed ID: 24870878 [No Abstract] [Full Text] [Related]
26. New therapies for mantle cell lyphoma. Williams ME Clin Adv Hematol Oncol; 2003 Dec; 1(12):708, 11. PubMed ID: 16258472 [No Abstract] [Full Text] [Related]
27. Mantle-cell lymphoma (multiple lymphomatous polyposis) of the entire GI tract. Michopoulos S; Petraki K; Matsouka C; Kastritis E; Chrysanthopoulou H; Dimopoulos MA J Clin Oncol; 2008 Mar; 26(9):1555-7. PubMed ID: 18349408 [No Abstract] [Full Text] [Related]
28. Late-onset neutropenia following viral bone marrow depression after rituximab therapy. Christopeit M; Haak U; Behre G Ann Hematol; 2008 Sep; 87(9):761-2. PubMed ID: 18350295 [No Abstract] [Full Text] [Related]
29. JC papovavirus leukoencephalopathy after first line treatment with CHOP and rituximab. Rey J; Belmecheri N; Bouayed N; Ivanov V; Coso D; Gastaut JA; Bouabdallah R Haematologica; 2007 Oct; 92(10):e101. PubMed ID: 18024364 [No Abstract] [Full Text] [Related]
30. CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology Group. Economopoulos T; Psyrri A; Dimopoulos MA; Kalogera-Fountzila A; Pavlidis N; Tsatalas C; Nikolaides C; Mellou S; Xiros N; Fountzilas G Cancer J; 2007; 13(5):327-34. PubMed ID: 17921732 [TBL] [Abstract][Full Text] [Related]
31. [Recent progress in the therapeutic strategy for follicular lymphoma and mantle cell lymphoma]. Ogura M Rinsho Ketsueki; 2006 Jun; 47(6):495-512. PubMed ID: 16862978 [No Abstract] [Full Text] [Related]
32. Ventricular tachycardia associated with infusion of rituximab in mantle cell lymphoma. Arai Y; Tadokoro J; Mitani K Am J Hematol; 2005 Apr; 78(4):317-8. PubMed ID: 15795913 [No Abstract] [Full Text] [Related]
33. Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome. Ohwada C; Nakaseko C; Sakai S; Takeda Y; Abe D; Takeuchi M; Sakaida E; Masuda S; Shimizu N; Cho R; Nishimura M; Kanai K; Misawa S; Kuwabara S Bone Marrow Transplant; 2009 May; 43(9):739-40. PubMed ID: 19043459 [No Abstract] [Full Text] [Related]
34. Is rituximab effective as a single agent in mantle-cell lymphoma? Grillo-López AJ Nat Clin Pract Oncol; 2005 Oct; 2(10):500-1. PubMed ID: 16205768 [No Abstract] [Full Text] [Related]
35. Complete response in a patient with colonic mantle cell lymphoma with multiple lymphomatous polyposis treated with combination chemotherapy using anti-CD20 antibody and cladribine. Watanabe T; Homma N; Ogata N; Saito H; Kanefuji T; Hasegawa K; Soga K; Shibasaki K; Endo T; Ajioka Y Gut; 2007 Mar; 56(3):449-50. PubMed ID: 17339260 [No Abstract] [Full Text] [Related]